Brazil researchers report more modest 50.4% efficacy for China's CoronaVac

RIO DE JANEIRO (Reuters) - A coronavirus vaccine developed by China's Sinovac showed 'general efficacy' of 50.4% in a late-stage trial in Brazil, the company's local partners said on Tuesday, revealing a more modest figure after pressure for more transparency. On Thursday, the Brazilian researchers had celebrated results showing 78% efficacy against mild COVID-19 cases, a rate they have since described as 'clinical efficacy.' Ricardo Palacios, medical director for clinical research at the Butantan biomedical center in Sao Paulo, said the new figure included infections classified as 'very mild' because they did not require clinical assistance. Piecemeal disclosure from global studies of the vaccine, called CoronaVac, have added to concerns that immunizations developed by Chinese producers are not subject to the same public scrutiny as U.S.

Reuters January 13, 2021 00:13:52 IST
Brazil researchers report more modest 50.4% efficacy for China's CoronaVac

Brazil researchers report more modest 504 efficacy for Chinas CoronaVac

RIO DE JANEIRO (Reuters) - A coronavirus vaccine developed by China's Sinovac showed "general efficacy" of 50.4% in a late-stage trial in Brazil, the company's local partners said on Tuesday, revealing a more modest figure after pressure for more transparency.

On Thursday, the Brazilian researchers had celebrated results showing 78% efficacy against mild COVID-19 cases, a rate they have since described as "clinical efficacy."

Ricardo Palacios, medical director for clinical research at the Butantan biomedical center in Sao Paulo, said the new figure included infections classified as "very mild" because they did not require clinical assistance.

Piecemeal disclosure from global studies of the vaccine, called CoronaVac, have added to concerns that immunizations developed by Chinese producers are not subject to the same public scrutiny as U.S. and European alternatives.

Researchers at Butantan delayed the announcement of their results three times, blaming a confidentiality clause in a contract with Sinovac.

Turkish researchers said last month that CoronaVac was 91.25% effective based on an interim analysis. Indonesia gave the vaccine emergency use approval on Monday based on interim data showing it is 65% effective.

Butantan officials said the design of the Brazilian study, focusing on frontline health workers during a severe outbreak in Brazil and including elderly volunteers, made it impossible to compare the results directly with other trials or vaccines.

(Reporting by Gabriel Stargardter and Pedro Fonseca; Editing by Brad Haynes)

This story has not been edited by Firstpost staff and is generated by auto-feed.

Updated Date:

TAGS:

Find latest and upcoming tech gadgets online on Tech2 Gadgets. Get technology news, gadgets reviews & ratings. Popular gadgets including laptop, tablet and mobile specifications, features, prices, comparison.

also read

Norway imposes new restrictions to prevent new wave, says PM
World

Norway imposes new restrictions to prevent new wave, says PM

OSLO (Reuters) -Norway will impose fresh restrictions to prevent a resurgence in the spread of the coronavirus, Prime Minister Erna Solberg said on Sunday, including a nationwide ban on serving alcohol in restaurants and bars and not inviting guests home.

Indigenous Venezuelan man accused of raiding military post dies in jail: rights group
World

Indigenous Venezuelan man accused of raiding military post dies in jail: rights group

(Reuters) - A Venezuelan member of the Pemon indigenous group accused of aiding a raid on a military post in late 2019 died on Sunday in a jail close to capital Caracas, rights group Penal Forum said in a tweet. Salvador Franco died just weeks after family members and activists reported he was suffering from health problems.

Norway imposes new restrictions to prevent new COVID-19 wave, says PM
World

Norway imposes new restrictions to prevent new COVID-19 wave, says PM

OSLO (Reuters) - Norway will impose fresh restrictions to prevent a resurgence in the spread of the coronavirus, Prime Minister Erna Solberg said on Sunday, including a nationwide ban on serving alcohol in restaurants and bars and not inviting guests home.